NYSE:BHC Bausch Health Cos (BHC) Stock Price, News & Analysis $5.77 +0.01 (+0.17%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$5.78 +0.01 (+0.17%) As of 08/8/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Bausch Health Cos Stock (NYSE:BHC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Bausch Health Cos alerts:Sign Up Key Stats Today's Range$5.75▼$5.8150-Day Range$4.49▼$7.1152-Week Range$4.25▼$9.85Volume843,013 shsAverage Volume1.45 million shsMarket Capitalization$2.14 billionP/E Ratio22.19Dividend YieldN/APrice Target$9.00Consensus RatingHold Company Overview Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. Read More Bausch Health Cos Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks93rd Percentile Overall ScoreBHC MarketRank™: Bausch Health Cos scored higher than 93% of companies evaluated by MarketBeat, and ranked 85th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingBausch Health Cos has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageBausch Health Cos has received no research coverage in the past 90 days.Read more about Bausch Health Cos' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth5.67% Earnings GrowthEarnings for Bausch Health Cos are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Cos is 22.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.88.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Cos is 22.19, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.76.Price to Book Value per Share RatioBausch Health Cos has a P/B Ratio of 14.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.56% of the float of Bausch Health Cos has been sold short.Short Interest Ratio / Days to CoverBausch Health Cos has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Bausch Health Cos has recently decreased by 10.58%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBausch Health Cos does not currently pay a dividend.Dividend GrowthBausch Health Cos does not have a long track record of dividend growth. Sustainability and ESG4.0 / 5Environmental Score-1.42 Percentage of Shares Shorted2.56% of the float of Bausch Health Cos has been sold short.Short Interest Ratio / Days to CoverBausch Health Cos has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Bausch Health Cos has recently decreased by 10.58%, indicating that investor sentiment is improving significantly. News and Social Media2.0 / 5News Sentiment0.55 News SentimentBausch Health Cos has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Bausch Health Cos this week, compared to 4 articles on an average week.Search InterestOnly 22 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of -12% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Bausch Health Cos to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Bausch Health Cos insiders have bought more of their company's stock than they have sold. Specifically, they have bought $35,870,767.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 8.05% of the stock of Bausch Health Cos is held by insiders.Percentage Held by Institutions78.65% of the stock of Bausch Health Cos is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bausch Health Cos' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Cos and its competitors with MarketBeat's FREE daily newsletter. Email Address BHC Stock News HeadlinesAnalysts Are Neutral on Top Healthcare Stocks: Bausch Health Companies (BHC), Sanofi (SNYNF)August 5, 2025 | theglobeandmail.comAnalyzing Bausch Health Cos (NYSE:BHC) and BridgeBio Pharma (NASDAQ:BBIO)August 2, 2025 | americanbankingnews.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 9 at 2:00 AM | Brownstone Research (Ad)Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Bausch Health Companies (BHC) and UnitedHealth (UNH)July 31, 2025 | theglobeandmail.comBausch Health reaffirms 2025 revenue target of $4.95B–$5.1B as debt reduction and pipeline expansion advanceJuly 30, 2025 | msn.comBausch Health Companies Inc. (BHC) Q2 2025 Earnings Call TranscriptJuly 30, 2025 | seekingalpha.comBausch Health Companies Inc. 2025 Q2 - Results - Earnings Call PresentationJuly 30, 2025 | seekingalpha.comBausch Health shares rise as Q2 earnings soar past estimatesJuly 30, 2025 | in.investing.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Cos' stock was trading at $8.06 at the beginning of 2025. Since then, BHC stock has decreased by 28.4% and is now trading at $5.77. How were Bausch Health Cos' earnings last quarter? Bausch Health Cos Inc. (NYSE:BHC) posted its earnings results on Wednesday, July, 30th. The company reported $0.90 EPS for the quarter, missing the consensus estimate of $0.97 by $0.07. The firm earned $2.57 billion during the quarter, compared to analysts' expectations of $2.47 billion. Bausch Health Cos had a net margin of 0.99% and a negative trailing twelve-month return on equity of 852.36%. Read the conference call transcript. Who are Bausch Health Cos' major shareholders? Top institutional shareholders of Bausch Health Cos include SG Americas Securities LLC (1.66%), MUFG Securities EMEA plc (0.92%), TD Asset Management Inc (0.24%) and Bank of Montreal Can (0.24%). Insiders that own company stock include John Paulson and Seana Carson. View institutional ownership trends. How do I buy shares of Bausch Health Cos? Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bausch Health Cos own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Cos investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Tesla (TSLA), Bristol Myers Squibb (BMY) and Gilead Sciences (GILD). Company Calendar Last Earnings7/30/2025Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - GENERIC DRG Sub-IndustryPharmaceutical Products Current SymbolNYSE:BHC CIK885590 Webwww.bauschhealth.com Phone(514) 744-6792Fax514-744-6272Employees20,700Year FoundedN/APrice Target and Rating Average Price Target for Bausch Health Cos$9.00 High Price Target$10.00 Low Price Target$8.00 Potential Upside/Downside+56.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$0.26 Trailing P/E Ratio22.19 Forward P/E Ratio1.31 P/E GrowthN/ANet Income-$46 million Net Margins0.99% Pretax Margin2.85% Return on Equity-852.36% Return on Assets5.25% Debt Debt-to-Equity Ratio141.90 Current Ratio1.31 Quick Ratio0.98 Sales & Book Value Annual Sales$9.63 billion Price / Sales0.22 Cash Flow$7.80 per share Price / Cash Flow0.74 Book Value$0.40 per share Price / Book14.43Miscellaneous Outstanding Shares370,130,000Free Float340,294,000Market Cap$2.14 billion OptionableOptionable Beta0.41 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NYSE:BHC) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.